Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis - Supplementary tables.docx
posted on 2022-06-27, 08:54authored byMagdalena ˙ Zeglen, Katarzyna ´Sladowska, Paweł Kawalec, Tomasz Brzostek
Table S1. Keywords used in the searches of medical databases to identify relevant studies for opicapone for the treatment of patients with Parkinson’s disease
Table S2. Basic characteristics of the studies included in the meta-analysis
Funding
Jagiellonian University Medical College, (Grant / Award Number)